Non Invasive Monitoring Systems Inc Quick Ratio (NIMU) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Non Invasive Monitoring Systems Inc  (NIMU)

Non Invasive Monitoring Systems Inc's Quick Ratio

NIMU's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Non Invasive Monitoring Systems Inc's Cash & cash equivalent grew by 566.67 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Non Invasive Monitoring Systems Inc's Quick Ratio to 0.1, Quick Ratio remained below Non Invasive Monitoring Systems Inc average.

Within Medical Equipment & Supplies industry 182 other companies have achieved higher Quick Ratio than Non Invasive Monitoring Systems Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3671, from total ranking in the first quarter 2026 at 3699.

Explain Quick Ratio?
How much Cash & cash equivalents NIMU´s has?
What are NIMU´s Current Liabilities?




NIMU Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q1
(Oct 31 2025)
Q4
(Jul 31 2025)
Q3
Y / Y Current Liabilities Change 68.45 % 30.08 % 492.55 % 18.45 % 492.55 %
Y / Y Cash & cash equivalent Change 5233.33 % 50 % -88 % -60 % -88 %
Quick Ratio MRQ 0.1 0.02 0 0.01 0
NIMU's Total Ranking # 3671 # 3699 # 4318 # #
Seq. Current Liabilities Change 35.61 % 24.21 % -4.12 % 4.3 % 4.72 %
Seq. Cash & cash equivalent Change 566.67 % 700 % -50 % 100 % -81.25 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 183
Healthcare Sector # 845
Overall Market # 3671


Quick Ratio Statistics
High Average Low
1.26 0.2 0
(Jan 31 2020)   (Dec 31 2025)




Financial Statements
Non Invasive Monitoring Systems Inc's Current Liabilities $ 2 Millions Visit NIMU's Balance sheet
Non Invasive Monitoring Systems Inc's Cash & cash equivalent $ 0 Millions Visit NIMU's Balance sheet
Source of NIMU's Sales Visit NIMU's Sales by Geography


Cumulative Non Invasive Monitoring Systems Inc's Quick Ratio

NIMU's Quick Ratio for the trailling 12 Months

NIMU Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Oct 31 2025)
12 Months
(Jul 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 65.42 % 97.2 % 147.66 % 76.25 % 128 %
Y / Y Cash & cash equivalent TTM Growth 227.12 % -55.56 % -78.29 % -54.95 % -75.62 %
Quick Ratio TTM 0.04 0.01 0.01 0.02 0.02
Total Ranking TTM # 4148 # 3096 # 3440 # #
Seq. Current Liabilities TTM Growth 15.97 % 7.18 % 26.25 % 5.41 % 38.25 %
Seq. Cash & cash equivalent TTM Growth 436.11 % 28.57 % -44 % -15.25 % -27.16 %


On the trailing twelve months basis NIMU Cash & cash equivalent more than doubled by 5233.33 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Non Invasive Monitoring Systems Inc's Quick Ratio to 0.04, Quick Ratio remained below NIMU average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Non Invasive Monitoring Systems Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3096 to 4148.

Explain Quick Ratio?
How much Cash & cash equivalents NIMU´s has?
What are NIMU´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 207
Healthcare Sector # 915
Within the Market # 4148


trailing twelve months Quick Ratio Statistics
High Average Low
1.37 0.23 0.01
(Oct 31 2019)   (Mar 31 2026)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Cytosorbents Corporation  0.24 $ 4.413  Millions$ 18.320  Millions
U S Physical Therapy Inc  0.23 $ 24.887  Millions$ 109.909  Millions
Accuray Incorporated  0.21 $ 40.623  Millions$ 191.405  Millions
Cerus Corporation  0.21 $ 17.980  Millions$ 85.790  Millions
Tenon Medical Inc   0.20 $ 1.677  Millions$ 8.305  Millions
Bioventus Inc   0.19 $ 29.457  Millions$ 154.471  Millions
Avita Medical Inc   0.19 $ 13.096  Millions$ 68.714  Millions
Bausch and Lomb Corp  0.19 $ 367.000  Millions$ 1,942.000  Millions
Dentsply Sirona Inc   0.18 $ 239.000  Millions$ 1,319.000  Millions
Adm Tronics Unlimited Inc   0.18 $ 0.223  Millions$ 1.235  Millions
Catheter Precision Inc   0.16 $ 1.839  Millions$ 11.166  Millions
Zimmer Biomet Holdings Inc   0.14 $ 410.000  Millions$ 3,013.500  Millions
Nexgel Inc   0.12 $ 1.692  Millions$ 14.440  Millions
Ufp Technologies Inc   0.12 $ 9.045  Millions$ 78.304  Millions
Solventum Corporation  0.11 $ 403.000  Millions$ 3,663.000  Millions
Nakamoto Inc   0.11 $ 19.072  Millions$ 179.474  Millions
Petvivo Holdings Inc   0.10 $ 0.135  Millions$ 1.313  Millions
The Pennant Group Inc   0.10 $ 15.273  Millions$ 152.406  Millions
Non Invasive Monitoring Systems Inc  0.10 $ 0.160  Millions$ 1.607  Millions
Boston Scientific Corporation  0.10 $ 749.000  Millions$ 7,530.000  Millions
Integer Holdings Corporation  0.10 $ 21.375  Millions$ 217.141  Millions
Bellevue Life Sciences Acquisition Corp  0.10 $ 1.500  Millions$ 15.734  Millions
National Vision Holdings Inc   0.09 $ 35.998  Millions$ 383.026  Millions
Becton Dickinson And Company  0.09 $ 864.000  Millions$ 9,404.000  Millions
Vivos Therapeutics Inc   0.09 $ 1.774  Millions$ 20.389  Millions
The Cooper Companies Inc   0.08 $ 154.900  Millions$ 1,866.600  Millions
Infusystem Holdings Inc  0.06 $ 0.964  Millions$ 15.300  Millions
Vsee Health Inc   0.06 $ 0.454  Millions$ 8.139  Millions
P3 Health Partners Inc   0.05 $ 21.272  Millions$ 388.581  Millions
Henry Schein Inc   0.05 $ 157.000  Millions$ 3,488.000  Millions

Date modified: 2026-08-31T07:55:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.